Sarah Boden
speaker
98 appearances
1 recordings
1 series
first heard Jul 2026
last heard 22 Jul
Sarah Boden’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 1 in all, peaking in Jul 2026 with 1.
Appearances
Well, we don't know a lot about that peptide.
And this is something I talked about with Paul Knopfler.
He's a cell and molecular biologist at the University of California, Davis.
And he told me that most of the peptide research has been in animals or like cells in petri dishes.
Right.
So what does Paul mean by toxic in this case?
Well, for example, something he's really worried about is angiogenesis.
It's the physiological process that creates new blood vessels.
And growing new blood vessels is great if you're trying to get over a sports injury like a torn ligament.
But with angiogenesis, it's hard to monitor where else blood vessels are growing in your body.
Exactly.
Good, bad, otherwise, we don't know.
Well, it's hard because you can't get a patent for these molecules unless they're reformulated in some novel way.
And pharmaceutical companies don't want to spend millions of dollars on drug trials unless they own the intellectual property.
Like, how is that happening?
OK, so people should know that in the U.S.
that for a lot of the more popular peptides, you cannot purchase medical grade quality.
They are not approved by the Food and Drug Administration.
So as a workaround, and maybe this is what the Pilates person was doing, people will go to the internet and get peptides from overseas vendors.
But what they're getting are research grade.
Showing 21–40 of 98 · page 2 of 5
← Previous
Next →